NCT03782025View on ClinicalTrials.gov

Effect of Vitamin K in Critically Ill Patients

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

February 13, 2019

Primary Completion Date

March 20, 2020

Study Completion Date

March 20, 2020

Conditions
Coagulation Factor DeficiencyCoagulopathy, ConsumptionVitamin K Deficiency
Interventions
DRUG

Phytomenadione

Blood samples will be taken before and after intravenously prescribed phytomenadione is given. Phytomenadione will be given independently of this study.

Trial Locations (2)

22185

Intensive and perioperative care. Skåne University Hospital. Lund, Lund

Skåne University Hospital, Lund

All Listed Sponsors
lead

Region Skane

OTHER

NCT03782025 - Effect of Vitamin K in Critically Ill Patients | Biotech Hunter | Biotech Hunter